Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Recurrent Hepatitis B After Liver Transplantation

NCT00059267 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00059267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00059267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Recurrent Hepatitis B After Liver Transplantation
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Observational
Overall status
Completed
Start date
March 31, 2001
Completion date
November 30, 2007
Enrollment
317 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute liver failure, cirrhosis, hepatitis b, hepatocellular carcinoma